Artificial Intelligence (AI) Clinical Trial Optimization Global Market Report 2026 | Capitalize on 15.7% CAGR with IQVIA, NVIDIA, Microsoft and Oracle

Bản dịch chưa sẵn sàng. Đang hiển thị bài viết gốc.

Company Logo Boost ROI through AI-led protocol design, patient matching, predictive analytics, decentralized monitoring and automated workflows that reduce delays and rework. Dublin, Nov. 12, 2026 (GLOBE NEWSWIRE) -- "Artificial Intelligence (AI) Clinical Trial Optimization Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. The global artificial intelligence (AI) clinical trial optimization market is experiencing rapid growth as pharmaceutical, biotechnology and clinical research organizations adopt advanced technologies to improve trial design, patient recruitment and data analysis. The market is projected to increase from $1.35 billion in 2025 to $1.